Autolus Therapeutics

Autolus Therapeutics is a Nasdaq-listed, UK-founded clinical-stage biopharmaceutical company developing next-generation CAR T-cell therapies for cancer and autoimmune disease, spun out of University College London.

Company Facts

• Headquarters: London, United Kingdom
• Type: public
• Website: https://www.autolus.com
• Industries: Biopharmaceuticals, Cell Therapy, Oncology